CD8⁺ T cell-based immunotherapy: Promising frontier in human diseases

Area of Science:

• Immunology
• Cell Biology
• Therapeutics

Background:

• T lymphocytes (T cells) are key to adaptive immunity, mediating pathogen elimination and immune memory.
• CD8+ cytotoxic T cells are critical effectors, directly eliminating infected cells via antigen recognition.
• CD8+ T cell-based immunotherapies are evolving as promising treatments for various diseases.

Purpose of the Study:

• To review current knowledge on CD8+ T cell-based immunotherapy for diverse diseases.
• To discuss the molecular basis, advancements, and limitations of these therapies.
• To provide a comprehensive overview of CD8+ T cells, including function and exhaustion markers.

Main Methods:

• Literature review of CD8+ T cell-based immunotherapy research.
• Analysis of molecular mechanisms underlying CD8+ T cell function.
• Summary of recent advances and challenges in the field.

Main Results:

• CD8+ T cells are vital for recognizing and eliminating infected or cancerous cells.
• Various CD8+ T cell-based therapeutic strategies have shown promise in preclinical and clinical studies.
• Understanding CD8+ T cell exhaustion is crucial for optimizing immunotherapy efficacy.

Conclusions:

• CD8+ T cell immunotherapy holds significant potential for treating autoimmune diseases, infectious diseases, and cancer.
• Further research is needed to overcome challenges and enhance the effectiveness of these therapies.
• This review provides a foundation for understanding CD8+ T cell immunotherapy advancements and applications.